Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarzyna M Targowska-Duda

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Neuroscience Letters|September 3, 2013
Role of the nicotinic receptor β4 subunit in the antidepressant activity of novel N,6-dimethyltricyclo[5.2.1.0²,⁶]decan-2-amine enantiomersKatarzyna M Targowska-Duda, Krzysztof Jozwiak, Hugo R Arias
The International Journal of Biochemistry & Cell Biology|June 7, 2011
Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
The International Journal of Biochemistry & Cell Biology|May 30, 2015
Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sitesHugo R Arias, Katarzyna M Targowska-Duda, Dominik Feuerbach, et al.
Molecules (Basel, Switzerland)|March 1, 2017
Recent Advances and Applications of Molecular Docking to G Protein-Coupled ReceptorsDamian Bartuzi, Agnieszka A Kaczor, Katarzyna M Targowska-Duda, et al.
Neurochemistry International|May 25, 2010
Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
Neurochemistry International|June 28, 2015
The antidepressant-like activity of nicotine, but not of 3-furan-2-yl-N-p-tolyl-acrylamide, is regulated by the nicotinic receptor β4 subunitHugo R Arias, Katarzyna M Targowska-Duda, Dominik Feuerbach, et al.
Biomolecules|January 23, 2020
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against SchizophreniaOliwia Koszła, Katarzyna M Targowska-Duda, Ewa Kędzierska, et al.
Journal of Biomolecular Structure & Dynamics|January 25, 2018
Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico studyKatarzyna M Targowska-Duda, Agnieszka A Kaczor, Krzysztof Jozwiak, et al.
Neuroscience Letters|April 9, 2014
Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptorKatarzyna M Targowska-Duda, Dominik Feuerbach, Grazyna Biala, et al.
Biochemistry|June 10, 2010
Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Neuroscience Letters|September 3, 2013
Role of the nicotinic receptor β4 subunit in the antidepressant activity of novel N,6-dimethyltricyclo[5.2.1.0²,⁶]decan-2-amine enantiomersKatarzyna M Targowska-Duda, Krzysztof Jozwiak, Hugo R Arias
The International Journal of Biochemistry & Cell Biology|June 7, 2011
Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational statesHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
The International Journal of Biochemistry & Cell Biology|May 30, 2015
Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sitesHugo R Arias, Katarzyna M Targowska-Duda, Dominik Feuerbach, et al.
Molecules (Basel, Switzerland)|March 1, 2017
Recent Advances and Applications of Molecular Docking to G Protein-Coupled ReceptorsDamian Bartuzi, Agnieszka A Kaczor, Katarzyna M Targowska-Duda, et al.
Neurochemistry International|May 25, 2010
Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
Neurochemistry International|June 28, 2015
The antidepressant-like activity of nicotine, but not of 3-furan-2-yl-N-p-tolyl-acrylamide, is regulated by the nicotinic receptor β4 subunitHugo R Arias, Katarzyna M Targowska-Duda, Dominik Feuerbach, et al.
Biomolecules|January 23, 2020
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against SchizophreniaOliwia Koszła, Katarzyna M Targowska-Duda, Ewa Kędzierska, et al.
Journal of Biomolecular Structure & Dynamics|January 25, 2018
Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico studyKatarzyna M Targowska-Duda, Agnieszka A Kaczor, Krzysztof Jozwiak, et al.
Neuroscience Letters|April 9, 2014
Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptorKatarzyna M Targowska-Duda, Dominik Feuerbach, Grazyna Biala, et al.
Biochemistry|June 10, 2010
Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptorsHugo R Arias, Dominik Feuerbach, Katarzyna M Targowska-Duda, et al.
Pageof 5